L. J. Vugt

Response to IL‐17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein‐coding and untranslated regions of the IL‐17A gene: results from a multicentre study of four European psoriasis cohorts

M. Coenen, J. Lambert, M. Hakobjan, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.